Remove Mergers Remove Pharmaceutical Remove Portfolio
article thumbnail

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

Global Newswire by Notified: M&A

Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKure’s portfolio of novel precision medicines in oncology

Mergers 53
article thumbnail

The Dynamic Landscape of Software Mergers and Acquisitions in 2024

Solganick & Co.

September 2, 2024 – The software mergers and acquisitions (M&A) marketplace has been bustling with activity in the first half of 2024, reflecting the sector’s robust growth and strategic consolidations. June 2024: TPG and CDPQ acquires Aareon for $4.2

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AstraZeneca to buy Canadian cancer specialist Fusion for $2.4bn

The Guardian: Mergers & Acquisitions

The Anglo-Swedish company struck an agreement to acquire Fusion Pharmaceuticals, which is developing next-generation radioconjugates that offer an alternative to chemotherapy and radiotherapy.

article thumbnail

Cooley’s 2023 Life Sciences M&A Year in Review: Potent Mix of Creativity and Resilience Spurs Activity Heading Into 2024

Cooley M&A

While the year saw an overall decline in M&A activity (down 17% from 2022) , total pharmaceuticals and life sciences deal value in 2023 increased by approximately 50% compared to 2022. Why did life sciences outperform the market? The last quarter of the year ended with a surge of deal activity.

M&A 52
article thumbnail

01-26-2024 Newsletter: When You Need to Return Cash in order to Raise More

OfficeHours

Buyout houses from Thoma Bravo to Permira are putting portfolio company sales high on the agenda for early 2024, as the industry seeks to return money to investors after a challenging period for exiting holdings. Some dealmakers claim the impact of elections on mergers and acquisitions is minimal. First, they want to earn.

article thumbnail

Beyond Traditional M&A: The Impact of Freelance Modeling on Modern Business Integration

Devensoft

Understanding Freelance Modeling in M&A In the realm of mergers and acquisitions (M&A), freelance modeling emerges as a dynamic and adaptive methodology, offering a departure from traditional approaches. Illustrating this transformative power, consider a merger between a software giant and a cybersecurity startup.

M&A 52
article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40